Definitive Contract 75F40121C00189
Award Date
9/22/21
Potential Completion Date
9/29/23
Potential Value
$667K
Federal Agency
Food and Drug Administration
Awardee
Purdue University
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost No Fee
Place of Performance
Silver Spring, MD 20993, USA
Solicitation Procedures
Basic Research
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Purdue University, a non-profit educational institution, is valued at $794,004.00. The award was made by the Food and Drug Administration (FDA) under its Broad Agency Announcement for Advanced Regulatory Science, which is a research and development program focused on modernizing regulatory science to support the FDA's mission. The contract requires Purdue to construct extensive databases and develop statistical analysis tools using Python and SAS software to...
This is a definitive contract awarded by the Food and Drug Administration (FDA), a civilian federal agency, to Purdue University, a public land-grant research university. The contract is for "HUMAN FOOD INSPECTIONS (EGG ONLY)" with a ceiling value of $865,389.06 and a completion date of October 15, 2027. The contract is a firm fixed-price arrangement with no set-aside designation. Purdue University is an experienced federal contractor and grantee, leveraging its research capabilities...
This firm fixed-price purchase order contract was awarded by the Food and Drug Administration to Purdue University, a 1862 land grant college and other not-for-profit educational institution located in West Lafayette, Indiana. The $250,000.00 contract is for environmental surveillance of the Indiana melon production agricultural region to detect foodborne bacterial pathogens. The contract does not have a set-aside designation. Based on Purdue University's extensive experience as a prime...
This is a $3,526,785.00 definitive, firm fixed-price contract awarded by the Food and Drug Administration (FDA) to the Regents of the University of Michigan, doing business as the University of Michigan, for Prediction of In Vivo Performance Analysis Services. The contract has no set-aside designation. The University of Michigan is providing a range of research and development services under this contract, including developing high-performance computational models to simulate small intestine...
This federal contract was awarded by the Department of Health and Human Services Food and Drug Administration (FDA) to Rutgers, The State University for an "Integrated Toolbox for Digital Design, Scale-up, Control, and Optimization of Advanced API Manufacturing Processes" with a potential value of $4,198,914.00. The contract is a definitive, cost-no-fee agreement with a completion date of September 30, 2024. Rutgers University is serving as the prime contractor, with Purdue...
The Department of Health and Human Services' Food and Drug Administration (FDA) awarded a $1,151,037 firm-fixed-price contract to the Regents of the University of Michigan for the development of "SEAMLESS DESIGN FOR MULTICOMPONENT ENDPOINTS FOR DRUG DEVELOPMENT IN RARE DISEASES." This definitive contract, which has a completion date of September 29, 2026, does not have a set-aside designation. The University of Michigan, a prominent U.S. state government-owned educational...
This federal contract award to The Trustees of Princeton University, valued at $2,692,771.30, is for an Integrated Platform for Continuous RNA Nanoparticle Formulation and Drying. The award was made by the Food and Drug Administration (FDA) and is not associated with a set-aside program. The contract supports research and development to advance regulatory science in areas of interest to the FDA, as outlined in a Broad Agency Announcement (BAA) solicitation. Key subcontractors include Seran...
This $399,991 federal contract was awarded by the U.S. Food and Drug Administration (FDA) to Midwestern University, a private, non-profit educational institution, to develop and validate population pharmacokinetic models for beta-lactam antibiotics used in critical care settings, specifically to guide treatment for patients with hospital-acquired pneumonia. The contract is a definitive, cost-no-fee contract with a completion date of September 29, 2025. This contract was issued under a Broad...
The U.S. Food and Drug Administration (FDA) awarded a $400,000.00 firm-fixed price contract to the Regents of the University of Michigan, Office of Research and Sponsored Projects (University of Michigan) to advance the science of in vitro, animal model, pharmacokinetic studies, and/or real-world evidence studies to facilitate drug development, including studies focused on antimicrobial resistance and drug development. This contract has a period of performance through March 31, 2026. The...
The U.S. Food and Drug Administration (FDA) awarded a $696,359 firm-fixed-price contract to Duke University's Office of Research Administration Division to conduct research and development activities in support of regulatory science and innovation. The contract, which does not have a set-aside designation, originated from a Broad Agency Announcement (BAA) that solicits advanced proposals across nine key areas to advance scientific knowledge in support of the FDA's mission to protect public...